Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model

Masuda, C; Sugimoto, M; Wakita, D; Monnai, M; Ishimaru, C; Nakamura, R; Kinoshita, M; Yorozu, K; Kurasawa, M; Kondoh, O; Yamamoto, K

Sugimoto, M (corresponding author), Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Prod Res Dept, 200 Kajiwara, Kamakura, Kanagawa 2478530, Japan.

CLINICAL & EXPERIMENTAL METASTASIS, 2020; 37 (1): 199

Abstract

Brain metastases are common in patients with non-small-cell lung cancer (NSCLC). The efficacy of bevacizumab, an anti-vascular endothelial growth fact......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索